- Home
- TECX vs ISOU Comparison
TECX vs ISOU Comparison
Compare TECX & ISOU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECX
- ISOU
- Stock Information
- Founded
- TECX 2019
- ISOU 2016
- Country
- TECX United States
- ISOU Canada
- Employees
- TECX N/A
- ISOU N/A
- Industry
- TECX
- ISOU
- Sector
- TECX
- ISOU
- Exchange
- TECX Nasdaq
- ISOU Nasdaq
- Market Cap
- TECX 387.1M
- ISOU 391.8M
- IPO Year
- TECX 2018
- ISOU N/A
- Fundamental
- Price
- TECX $19.02
- ISOU $8.76
- Analyst Decision
- TECX Buy
- ISOU
- Analyst Count
- TECX 6
- ISOU 0
- Target Price
- TECX $79.17
- ISOU N/A
- AVG Volume (30 Days)
- TECX 515.4K
- ISOU 114.2K
- Earning Date
- TECX 11-06-2025
- ISOU 11-26-2025
- Dividend Yield
- TECX N/A
- ISOU N/A
- EPS Growth
- TECX N/A
- ISOU N/A
- EPS
- TECX N/A
- ISOU N/A
- Revenue
- TECX N/A
- ISOU N/A
- Revenue This Year
- TECX N/A
- ISOU N/A
- Revenue Next Year
- TECX N/A
- ISOU N/A
- P/E Ratio
- TECX N/A
- ISOU N/A
- Revenue Growth
- TECX N/A
- ISOU N/A
- 52 Week Low
- TECX $13.70
- ISOU $5.72
- 52 Week High
- TECX $61.07
- ISOU $11.50
- Technical
- Relative Strength Index (RSI)
- TECX 61.68
- ISOU 40.71
- Support Level
- TECX $16.98
- ISOU $9.83
- Resistance Level
- TECX $18.77
- ISOU $11.50
- Average True Range (ATR)
- TECX 1.30
- ISOU 0.82
- MACD
- TECX 0.54
- ISOU -0.27
- Stochastic Oscillator
- TECX 96.12
- ISOU 9.06
About TECX Tectonic Therapeutic Inc. Common Stock
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
About ISOU IsoEnergy Ltd. Common Shares
IsoEnergy Ltd is engaged in the acquisition, exploration, and evaluation of uranium properties in Canada. The company's project profile includes Thorburn Lake, Radio, Geiger, and Larocque East. and others. It operates in Canada, the United States, and Australia.